Discussion
Under-recruitment and the high costs of recruiting for clinical trials have been well documented in the literature [The proportion of sites in rural locations and low SES areas were observed to be slightly greater in the most efficient and lowest cost category. While our findings regarding rural practices appear to correspond with that reported in a previous study, ASPREE [We observe that sites that more successfully converted eligible patients to randomised (Fig. 